Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc. > Level II Quote
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(664)
•••
Comment by DeathXray33on Aug 09, 2024 2:02pm
171 Views
Post# 36171807

RE:RE:RE:RE:RE:RE:RE:RE:RE:Level II Quote

RE:RE:RE:RE:RE:RE:RE:RE:RE:Level II Quote
Lesalpes29 wrote: Don't understand why Morgan Stanley is doing this. But it seems that they are selling at the bid price? An other thing, dont know if Morgan Stanley could be involve with the actual PP by tranches? 


"Morgan Stanley admitted to making false statements in connection with block trades from 2018 through August 2021. Its $249.4 million payment includes fines, restitution and the forfeiture of ill-gotten gains. "The integrity of our financial markets requires a level playing field," said James Smith, assistant director in charge of the FBI's New York office, which helped investigate the matter. "When individuals and institutions intentionally tip the scales there must be consequences." https://www.reuters.com/business/finance/sec-charges-morgan-stanley-former-exec-passi-with-fraud-block-trading-business-2024-01-12/
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities